Table 3 Health-related quality of life (HRQL) comparing COVID-19 intensive care unit survivors who received corticosteroid treatment versus without, presented as mean score differences (MSD) with 95% confidence intervals (CI). No corticosteroidswere used as a reference
Health-related quality of life domains | No corticosteroids | Corticosteroids | Unadjusted analysis | Adjusted analysis |
|---|---|---|---|---|
Mean scores (95%CI) | Mean scores (95%CI) | MSD (95%CI) | MSD (95%CI) | |
Total number | 41 | 128 | ||
Survivors | ||||
Physical function | 66 (58–75) | 65 (60–70) | -1.7 (-11.3 to 8.0) | 0.8 (-8.3 to 9.8) |
Role physical | 43 (29–57) | 46 (38–54) | 2.6 (-13.3 to 18.4) | 6.0 (-9.5 to 21.6) |
Bodily pain | 64 (55–74) | 68 (63–73) | 3.7 (-6.5 to 13.9) | 4.8 (-5.3 to 15.0) |
General health | 52 (45–58) | 56 (52–60) | 4.3 (-3.4 to 12.0) | 5.2 (-2.3 to 12.9) |
Vitality | 50 (43–57) | 54 (49–58) | 3.9 (-4.7 to 12.6) | 3.8 (-4.8 to 12.4) |
Social function | 64 (56–73) | 67 (62–72) | 3.1 (-7.1 to 13.4) | 4.4 (-5.6 to 14.5) |
Role emotional | 59 (46–72) | 69 (62–76) | 10.2 (-4.4 to 24.8) | 12.4 (-2.1 to 26.9) |
Mental health | 68 (62–75) | 73 (70–77) | 4.9 (-2.3 to 12.0) | 4.4 (-2.8 to 11.7) |